Clinical Trial Update: ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on ShenFu Injection for myocardial protection in patients with acute ST-segment elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Shenfu Injection

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED